1. Home
  2. Stocks
  3. Vilinbio Share Price

Vilin Bio Med Share Price

Pharmaceuticals Small Cap

₹21.00 0.00 (0.00%)

05 Nov, 2024 16:51

SIP TrendupStart SIP in VILINBIO

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹21
  • High
  • ₹21
  • 52 Week Low
  • ₹15
  • 52 Week High
  • ₹30
  • Open Price₹21
  • Previous Close₹21
  • Volume4,000

Investment Returns

  • Over 1 Month -2.78%
  • Over 3 Month + 23.53%
  • Over 6 Month 0%
  • Over 1 Year 0%
SIP Lightning

Smart Investing Starts Here Start SIP with Vilin Bio Med for Steady Growth!

Vilin Bio Med Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • PEG Ratio
  • Market Cap Cr
  • 29
  • P/B Ratio
  • 1.3
  • Average True Range
  • 1.87
  • EPS
  • 0.1
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.97
  • RSI
  • 49.18
  • MFI
  • 79.49

Vilin Bio Med Financial

IndicatorMar 24Mar 23
Revenue From Operations [Gross]15.8012.31
Revenue From Operations [Net]15.8012.31
Total Operating Revenues15.8012.31
Total Revenue16.1312.34
Total Expenses15.9010.56
Profit/Loss Before Tax0.231.78
Profit/Loss For The Period0.161.25
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-5.30-1.66
Net Cash Used In Investing Activity0.32-0.03
Net Cash Used in Finance Activity10.991.68
Net Inc/Dec In Cash And Equivalent6.010.00
Cash And Equivalent End Of Year6.050.03
IndicatorMar 24Mar 23
Total Share Capital13.959.95
Total Non-Current Liabilities0.290.50
Total Current Liabilities9.276.50
Total Capital And Liabilities32.4017.68
Total Non-Current Assets13.794.40
Total Current Assets18.6213.28
Total Assets32.4017.68
Indicator20242023
EBIT Margin (%)6.3919.73
Return On Capital Employed (%)4.3721.73
Return On Equity (%)0.7111.65
Long Term Debt To Equity (%)0.914.03
Book Value/Share (INR)16.3710.73
Indicator20242023
EBIT Margin (%)6.3919.73
Return On Capital Employed (%)4.3721.73
Return On Equity (%)0.7111.65
Long Term Debt To Equity (%)0.914.03
Book Value/Share (INR)16.3710.73

Vilin Bio Med Technicals

EMA & SMA

Current Price
₹21.00
0 (0%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹21.66
  • 50 Day
  • ₹20.55
  • 100 Day
  • ₹20.37
  • 200 Day
  • ₹21.15

Resistance and Support

20.67 Pivot Speed
  • R3 22.33
  • R2 21.67
  • R1 21.33
  • S1 20.33
  • S2 19.67
  • S3 19.33

Is Vilin Bio Med Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Vilin Bio Med Ltd has an operating revenue of Rs. 51.05 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. It is currently FORMING a base in its weekly chart and is trading around 24% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Vilin Bio Med Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-30 Quarterly Results
2024-05-29 Audited Results
2023-11-10 Quarterly Results

Vilin Bio Med F&O

Vilin Bio Med Shareholding Pattern

64.09%
34.46%
1.45%
  • NSE Symbol
  • VILINBIO
  • BSE Symbol
  • Managing Director
  • Mr. Viswa Prasad Sadhanala
  • ISIN
  • INE0L4V01013

Vilin Bio Med FAQs

Vilin Bio Med share price is ₹21 As on 05 November, 2024 | 16:37

The Market Cap of Vilin Bio Med is ₹29.3 Cr As on 05 November, 2024 | 16:37

The P/E ratio of Vilin Bio Med is As on 05 November, 2024 | 16:37

The PB ratio of Vilin Bio Med is 1.3 As on 05 November, 2024 | 16:37

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.